DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Enoxolone
Enoxolone
Nitrate Prodrugs Able to Release Nitric Oxide in a Controlled and Selective
Specifications of Approved Drug Compound Library
(12) Patent Application Publication (10) Pub. No.: US 2010/0221245 A1 Kunin (43) Pub
)&F1y3x PHARMACEUTICAL APPENDIX to THE
NINDS Custom Collection II
Hazard Assessment of Glycyrrhizic Acid from Liquorice
Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr
MMC International BV
Pharmaceutical Appendix to the Tariff Schedule 2
Dalton Pharma Catalogue Steroids 12-19-12
EUROPEAN PHARMACOPOEIA 10.0 Index 1. General Notices
Pairwise Comparisons
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
NG198 Evidence Review F1
2250.Full.Pdf
Stembook 2018.Pdf
Tariff Schedule of Canada
Top View
Enoxolone Suppresses Apoptosis in Chondrocytes and Progression of Osteoarthritis Via Modulating the ERK1/2 Signaling Pathway
Wo 2009/132050 A2
EUROPEAN PHARMACOPOEIA 10.3 to Aid Users the Index Includes a Reference to the Supplement in Which the Latest Version of a Text
NG198 Evidence Review E1
NG198 Evidence Review G
Known Bioactive Library: Selleck Bioactive 10Mm, 3.33Mm, 1.11Mm
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
GSK3B Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cell Properties and Is a Novel Drug Target for Triple-Negative Breast Cancer
A Drug Library Screen Identifies Carbenoxolone As Novel FOXO
Transdermal Device Containing
(12) United States Patent (10) Patent No.: US 7,906,140 B2 Bromley Et Al
Mechanisms of Steroid-Induced
EUROPEAN PHARMACOPOEIA 10.6 to Aid Users the Index
)&F1y3x PHARMACEUTICAL APPENDIX to the HARMONIZED
Customs Tariff - Schedule Xxi - 1
WO 2016/040896 Al FIG. JO
Harmonized Tariff Schedule of the United States (2005) Annotated for Statistical Reporting Purposes
Harmonized Tariff Schedule of the United States (2006) (Rev
Supplementary Table 1: U.S
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Screening of Chemopreventive Agents in Animal Models: Results on Reproducibility, Agents of a Given Class, and Agents Tested During Tumor Progression Ronald A
WO 2U11/132171 Al
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
Figure 1 METHODS and COMPOSITIONS for the TREATMENT of DISORDERS ASSOCIATED with DEFECTS of the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE OR PROTEIN
Pharmaceutical Appendix to the Tariff Schedule 2
(12) United States Patent (10) Patent No.: US 8,802,596 B2 Rogers Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Enoxolone Potassium (Potassium Glycyrrhetinate) Has Been Used Spasgan (Спазган); Spasmalgon (Спазмалгон); Spasmalin (Спазмалин); As for Infliximab, P.69
Pharmaceuticals Appendix
Drug Effects Viewed from a Signal Transduction Network Perspective
WO 2012/170676 Al 13 December 2012 (13.12.2012) P O P C T
ENOXOLONE Technical -Scientific Report
List of European Pharmacopoeia Reference Standards
The Effects of Xenobiotics on Steroidogenesis in Human: in Vitro and in Vivo Investigations
Glycyrrhiza Glabra L
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
EUROPEAN PHARMACOPOEIA 10.1 to Aid Users the Index Includes a Reference to the Supplement in Which the Latest Version of a Text